Trading / Browse Companies / Prosetta Biosciences stock

Prosetta Biosciences Stock

prosetta.comBioTechFounded: 1900Funding to Date: $40.04MM

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Buy or sell Prosetta Biosciences stock
Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

OverviewFinancingsValuation

Team

Management Team

Thomas Higgins
Founding Chief Executive & Chairman
Karl Manheim
Co-Founder & Board Member
Vishwanath Lingappa Ph.D
Co-Founder, Board Member, Chief Technology Officer & Chief Executive Officer

Board Members

Charles Parrish
CJ Sylvester
Fred Alger Management
Dale Bredesen MD
David Keys
Karl Manheim
Thomas Higgins
Vishwanath Lingappa Ph.D

Other companies like Prosetta Biosciences in the BioTech sector

Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Ginkgo Bioworks
Sector
BioTech
Last Round Est. Valuation
$4.89B
PROCEPT BioRobotics
Sector
BioTech
Last Round Est. Valuation
$872.62MM
Synthego
Sector
BioTech
Last Round Est. Valuation
$486.63MM
eFFECTOR Therapeutics
Sector
BioTech
Last Round Est. Valuation
$186.12MM
Human Longevity
Sector
BioTech
Last Round Est. Valuation
$50.4MM
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Arsenal Biosciences
Sector
BioTech
Last Round Est. Valuation
$185MM
Caris Life Sciences
Sector
BioTech
 
 

News

PRNewswire 03/28/2017
Purch Expands Industry-Leading Yield Optimization Platform
NEW YORK, March 28, 2017 /PRNewswire/ -- Purch, a digital publishing and marketplace platform, announced today that...

Trending Companies

Frequently Asked Questions